Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DIROXIMEL vs DOCETAXEL ANHYDROUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DIROXIMEL vs DOCETAXEL ANHYDROUS: Safety Overview

Metric DIROXIMEL DOCETAXEL ANHYDROUS
Total FAERS Reports 10,626 1,084
Deaths Reported 305 5
Death Rate 2.9% 0.5%
Hospitalizations 2,113 10
Average Patient Age 52.8 yrs 55.6 yrs
% Female Patients 79.0% 99.2%
FDA Approval Date Nov 12, 2025 N/A
Manufacturer Biogen Inc. Mylan Institutional LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A